| FICO |
Report |
Non-GAAP diluted EPS |
BEAT |
pred ~$12.25 vs. cons $11.91 |
MEDIUM |
| FICO |
Report |
Total revenue |
BEAT |
pred ~$702M vs. cons $689.7M |
MEDIUM |
| FICO |
Report |
Scores revenue |
BEAT |
pred ~$486M vs. cons $475M |
MEDIUM |
| FICO |
Guide |
FY2026 revenue guidance |
BETTER |
guide ~$2.48B vs. cons $2.47B (FY2026) |
MEDIUM |
| FICO |
Guide |
FY2026 non-GAAP EPS guidance |
BETTER |
guide ~$41.20 vs. cons $40.54 (FY2026) |
MEDIUM |
| FICO |
Return |
Day-1 residual (stock − beta × S&P 500) |
+4.5% |
— |
MEDIUM |
| FICO |
Return |
5-day cumulative residual |
+5.5% (FOLLOW-THROUGH) |
A ~$41.20 FY2026 EPS guide versus $40.54 consensus implies a ~$0.66 out-period lift, while ~$2.48B revenue versus $2.47B supports continued FY2027 estimate revisions; a ~$12.25 quarter versus $11.91 should therefore extend the initial +4.5% residual move rather than fade. |
MEDIUM |